Keyphrases
Science Experts
100%
Homozygous Familial Hypercholesterolemia (HoFH)
100%
Expert Panel
100%
Clinical Genetic Testing
100%
Genetic Testing
42%
Patient Phenotype
14%
Standard of Care
14%
Lipid-lowering
14%
Apolipoprotein B (Apo B)
14%
Potential Needs
14%
Pathogenic Variants
14%
High Cardiovascular Risk
14%
Genetic Disease
14%
Global Experts
14%
Low-density Lipoprotein Receptor
14%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
14%
Risk Stratification
14%
Therapy Initiation
14%
Consensus Panel
14%
Expert Consensus
14%
Adherence to Therapy
14%
Definitive Diagnosis
14%
Expected Outcomes
14%
Biochemistry, Genetics and Molecular Biology
Familial Hypercholesterolemia
100%
Genetic Screening
100%
Awareness
14%
Patient Compliance
14%
Kexin
14%
Subtilisin
14%
Apolipoprotein B
14%
Lipid
14%
LDL Receptor
14%
Genetic Disorder
14%
Proprotein Convertase
14%